JPMorgan maintains Fisher&Paykel Healthcare at 'underweight' with a price target of AUD21.50

  • Investing.com
JPMorgan maintains Fisher&Paykel Healthcare at 'underweight' with a price target of AUD21.50

An analyst from JPMorgan maintained Fisher&Paykel Healthcare (ASX: FPH ) at 'underweight' with a price target of AUD21.50 from a prior price target of AUD23.20.

Prior to this rating, Fisher&Paykel Healthcare had 1 buy ratings, 3 hold ratings, and 2 sell ratings.

For consensus analyst estimates and price targets on Fisher&Paykel Healthcare, click here. For more news on Fisher&Paykel Healthcare, click here.

Fisher&Paykel Healthcare's stock price closed at $22.75. They are down -10.85% in the last month and up 22.91% in the last 12 months.

According to Investing Pro, Fisher&Paykel Healthcare's fair value is $17.04, a downside of 24.85%. Fisher&Paykel Healthcare's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Fisher&Paykel Healthcare's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100